Unresectable pancreatic adenocarcinoma: do we know who survives?

HPB

Volumn 12, Issue 8, 2010, Pages 561-566

  Jamal, Mohammad H ^a   Doi, Suhail A ^b   Simoneau, Eve ^a   Khalil, Jad Abou ^a   Hassanain, Mazen ^a   Chaudhury, Prosanto ^a   Tchervenkov, Jean ^a   Metrakos, Peter ^a   Barkun, Jeffrey S ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

endoscopic palliation; surgical palliation; unresectable pancreatic adenocarcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANADA; FEMALE; HUMAN; JAUNDICE; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PAIN; PALLIATIVE THERAPY; PANCREAS TUMOR; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGISTER; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL MODEL; SURVIVAL RATE; TIME; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; JAUNDICE; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PAIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; QUEBEC; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79953016646     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00220.x     Document Type: Article

References (26)

1. Monkemuller, K., Fry, L.C., Malfertheiner, P., Pancreatic cancer is ‘always non-resectable’. Dig Dis 25 (2007), 285–288.
2. Allendorf, J.D., Lauerman, M., Bill, A., DiGiorgi, M., Goetz, N., Vakiani, E., Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. J Gastrointest Surg 12 (2008), 91–100.
3. Bauer, J., Capra, S., Battistutta, D., Davidson, W., Ash, S., Compliance with nutrition prescription improves outcomes in patients with unresectable pancreatic cancer. Clin Nutr 24 (2005), 998–1004.
4. Srikureja, W., Chang, K.J., Endoscopic palliation of pancreatic adenocarcinoma. Curr Opin Gastroenterol 21 (2005), 601–605.
5. Abraham, N.S., Barkun, J.S., Barkun, A.N., Palliation of malignant biliary obstruction: a prospective trial examining impact on quality of life. Gastrointest Endosc 56 (2002), 835–841.
6. Yokoyama, N., Shirai, Y., Wakai, T., Nagakura, S., Akazawa, K., Hatakeyama, K., Jaundice at presentation heralds advanced disease and poor prognosis in patients with ampullary carcinoma. World J Surg 29 (2005), 519–523.
7. Smith, R.A., Dajani, K., Dodd, S., Whelan, P., Raraty, M., Sutton, R., Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma. Ann Surg Oncol 15 (2008), 3138–3146.
8. Smith, A.C., Dowsett, J.F., Russell, R.C., Hatfield, A.R., Cotton, P.B., Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 344 (1994), 1655–1660.
9. Raikar, G.V., Melin, M.M., Ress, A., Lettieri, S.Z., Poterucha, J.J., Nagorney, D.M., Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncol 3 (1996), 470–475.
10. Born, P., Rosch, T., Bruhl, K., Ulm, K., Sandschin, W., Frimberger, E., Longterm results of endoscopic treatment of biliary duct obstruction due to pancreatic disease. Hepatogastroenterology 45 (1998), 833–839.
11. Isayama, H., Komatsu, Y., Tsujino, T., Yoshida, H., Tada, M., Shiratori, Y., Polyurethane-covered metal stent for management of distal malignant biliary obstruction. Gastrointest Endosc 55 (2002), 366–370.
12. Maire, F., Hammel, P., Ponsot, P., Aubert, A., O'Toole, D., Hentic, O., Longterm outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol 101 (2006), 735–742.
13. Greenwood, M., The ‘Error of Sampling’ Survivorship Tables. Reports on Public Health and Medical Subjects. Ed, 1926, Stationery Office, London.
14. De Castro, S.M., Houwert, J.T., Lagard, S.M., Busch, O.R., Van Gulik, T.M., Gouma, D.J., POSSUM predicts survival in patients with unresectable pancreatic cancer. Dig Surg 26 (2009), 75–79.
15. Park, J.K., Yoon, Y.B., Kim, Y.T., Ryu, J.K., Yoon, W.J., Lee, S.H., Survival and prognostic factors of unresectable pancreatic cancer. J Clin Gastroenterol 42 (2008), 86–91.
16. Morganti, A.G., Massaccesi, M., La Torre, G., Caravatta, L., Piscopo, A., Tambaro, R., A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 17 (2010), 194–205.
17. Kuhlmann, K.F., De Castro, S.M., Wesseling, J.G., Ten Kate, F.J., Offerhaus, G.J., Busch, O.R., Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 40 (2004), 549–558.
18. Fujino, Y., Ueda, T., Kamigaki, T., Takase, S., Ajiki, T., Kamoda, Y., Impact of gemcitabine on the survival of patients with stage IV pancreatic cancer. Pancreas 34 (2007), 335–339.
19. Burris, H.A. III, Moore, M.J., Andersen, J., Green, M.R., Rothenberg, M.L., Modiano, M.R., Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15 (1997), 2403–2413.
20. Van Den Bosch, R.P., Van Der Schelling, G.P., Klinkenbijl, J.H., Mulder, P.G., Van Blankenstein, M., Jeekel, J., Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg 219 (1994), 18–24.
21. Lillemoe, K.D., Pitt, H.A., Palliation. Surgical and otherwise. Cancer 78 (1996), 605–614.
22. Fazal, S., Saif, M.W., Supportive and palliative care of pancreatic cancer. JOP 8 (2007), 240–253.
23. Sener, S.F., Fremgen, A., Menck, H.R., Winchester, D.P., Pancreatic cancer: a report of treatment and survival trends for 100 313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg 189 (1999), 1–7.
24. Krishnan, S., Rana, V., Janjan, N.A., Abbruzzese, J.L., Gould, M.S., Das, P., Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107 (2006), 2589–2596.
25. Cubiella, J., Castells, A., Fondevila, C., Sans, M., Sabater, L., Navarro, S., Prognostic factors in non-resectable pancreatic adenocarcinoma: a rationale to design therapeutic trials. Am J Gastroenterol 94 (1999), 1271–1278.
26. Muller, M.W., Friess, H., Koninger, J., Martin, D., Wente, M.N., Hinz, U., Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg 195 (2008), 221–228.